**Authors and affiliations**

<div style="font-size: larger;">
Vojtech Petr<sup>1,2</sup>, Samuel L. Liu<sup>3</sup>, Filip Tichanek<sup>1</sup>, Felix Poppelaars<sup>2</sup>, Brandon Renner<sup>2</sup>, Jennifer Laskowski<sup>2</sup>, Shrey Purohit<sup>2</sup>, Ming Zhao<sup>3</sup>, Diana Jalal<sup>4,5</sup>, Peter S. Heeger<sup>6,#</sup>, Joshua M. Thurman<sup>3,#</sup>
</div>

<br>

<sup>1</sup> Institute for Clinical and Experimental Medicine, Prague, Czech Republic     
<sup>2</sup> Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA     
<sup>3</sup> Feinberg Cardiovascular and Renal Research Institute, Northwestern University, Chicago, IL, USA      
<sup>4</sup> Department of Medicine, Carver College of Medicine, University of Iowa, IA, USA 
<sup>5</sup> Iowa City VA HCS, Iowa City, IA, USA
<sup>6</sup> Departments of Medicine, Surgery and Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, CA, USA 
<sup>#</sup> Co-senior authors, contributed equally

---------------------------------------------------------------------------------------------------

This is a statistical report of the study titled ***Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction *** currently *under review* in the [*American Journal of Transplantation*](https://www.amjtransplant.org/) journal.

When using this code or data, cite the original publication:

> TO BE ADDED

BibTex citation for the original publication:

> TO BE ADDED

---------------------------------------------------------------------------------------------------

Original [GitHub repository](https://github.com/filip-tichanek/infliximab_nAb): https://github.com/filip-tichanek/infliximab_nAb

Statistical **reports** can be found on the [reports hub](https://filip-tichanek.github.io/infliximab_nAb/)

----------------------------------------------------------------------------------------------------


